Motley Fool

Why Shares of Ocugen Climbed Today

Shares of biotech company Ocugen (NASDAQ: OCGN) jumped nearly 13% today as the latest COVID figures show a significant rise in cases, hospitalizations, and deaths — especially among the unvaccinated. Over the last two weeks, COVID cases are up 140%, while hospitalizations and deaths are up by one-third. Ocugen has partnered with Bharat Biotech, the company responsible for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.


Please enter your comment!
Please enter your name here